ArticleCurrent oncology (Toronto, Ont.)2024

Exploration of Germline Correlates and Risk of Immune-Related Adverse Events in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors.

Emma Titmuss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.